Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




A Computerized Test Battery Sensitive to Mild and Severe Brain Injury
Link ID 4886
Title A Computerized Test Battery Sensitive to Mild and Severe Brain Injury
Url http://www.medscape.com/viewarticle/571285?src=rss
Description Computerized tests like CNS VS allow clinicians the advantage of precise neurocognitive measurement in the service of diagnosis and appropriate treatment.
The Medscape Journal of Medicine
Category Articles > Business of Medicine
Keywords
Date Apr 16, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. U.S. Congress Passes Mental Health Coverage Boost
  A measure boosting insurance coverage for mental illness and treatment of drug and alcohol addiction secured final U.S. congressional passage on Friday as part of financial industry bailout legislation. Reuters Health Information
Category:   Articles > Business of Medicine


2. What Broke Me
  On a medical mission to an impoverished country, a medical student experiences the human toll of healthcare disparities.
Medscape Med Students
Category:   Articles > Business of Medicine


3. WHO Health Chief Urges Fast Action on Cheap Drugs
  World Health Organisation (WHO) chief Margaret Chan called for quick global agreement on Monday to ensure people in poor countries can get the drugs they need at affordable prices. Reuters Health Information
Category:   Articles > Business of Medicine


4. U.S. Lawmakers Investigate Wyeth Vitamin Claims
  Two U.S. lawmakers are investigating advertising claims by Wyeth that promote its Centrum Cardio vitamin as a cholesterol-lowering product, according to a letter to the company released on Friday. Reuters Health Information
Category:   Articles > Business of Medicine


5. Recentin Fails Lung Cancer Trial
  A clinical trial of Recentin as a treatment for non-small-cell lung cancer has been halted by AstraZeneca, Plc, after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS